Feedback

Prof. Swati Biswas

Professor,
Department of Pharmacy

Birla Institute of Technology & Science, Pilani
Hyderabad Campus
Jawahar Nagar, Kapra Mandal
Dist.-Medchal-500 078
Telangana, India

Projects

Intra-mural projects as principal investigator

Sr. No

Title of the projects

Type

Co-PI

Fund

Duration

1

Lyotropic liquid crystalline systems development and its preclinical evaluations as wound healing spray dressing and multifunctional targeted combination cancer therapy

BITS-RMIT

Sampa Sarkar, Charlotte Conn, Sarvesh Soni

-

2024-2028

2

Formulation based strategy to design mitochondrial targeting anti-microbial peptide-based therapeutics for cancer and eye-infections

BITS-La-Trobe

Adam Mechler

-

2024-2028

3

 Development of smart wound protecting material to combat drug-resistant bacteria in diabetic foot ulcer

SPARKLE

Sayan Das

2 L

2023-2025

4

De novo design of antibacterial peptides to combat antimicrobial resistance

CDRF

Debirupa Mitra,

Arnab Dutta

10 L

2023-2025

 

Extra-mural projects as principal investigator (Completed and ongoing)

Sr. No

Title of the projects

Funding agency

Fund

Duration

1

Nanozyme incorporated Light-Responsive Hydrogel as Angiogenic Antibacterial Wound Dressing for Treating Diabetic Foot Ulcer

CSIR-ASPIRE

29.71 L

2024-2027

2

Antibacterial Nanozyme-Laden in situ Light-Responsive Hydrogel for Tissue Regeneration and Quorum-Sensing Inhibition to Revert Antimicrobial Resistance in Diabetic Foot Ulcers

ICMR

48.02 L

2023-2026

3

Formulation based strategy to design membrane targeting anti-microbial peptide-based therapeutics for cancer and eye infections

SPARC

71.16L

2024-2026

7

Revolutionizing Phototherapy with Hypoxia-Reversing Photothermal/ Photodynamic Nanoparticles-Laden In Situ Gel for Non-Invasive Tumor Ablation in Oral Cancer

ICMR

53.13 L

2023-2026

8

Brain-Targeted Antibacterial Nanomedicine to Revolutionize the Existing Therapy for Bacterial Meningitis

ICMR

55.08 L

2023-2026

9

3D-Bioprinted Contact Lens Embedding Host-Defense Peptide S100A12 as Precision Medicine for Bacterial Keratitis

DBT

39.10 L

2023- Feb 2025

10

Carbon dioxide-fueled Janus Motors for Targeted Delivery of Therapeutic Cargo in Helicobacter pylori Infection

MoE-STARS

46.85 L

2023-2026

11

Tailor-made, Tumor-Targeted Vitaprotein Nanoparticles of Lapatinib and Letrozole as NanoChemo-Cocktail for Hormone-Receptor-Amplified Advanced Metastatic Breast Cancers Treatment

ICMR

29.76 L

2023-2026

12

Near-Infrared Light Degradable Nanomicellar Chemo-Photodynamic Therapy using Aerobic Chlorin e6 Conjugate for Oropharyngeal Carcinomas

DST-SERB-Core Research Grant

30.72 L

2019-2022

13

Understanding the role of antimicrobial peptide S100A12 (Calgranulin C) in Host Defense during Pseudomonas Keratitis and Developing nano-tools for efficient Delivery of S100A12

DST-SERB (E.M.R./2016/001514)

(PI from BITS-Pilani)

55 L

2017-2020

14

Development of paclitaxel nano-formulation (CONSULTANCY)

Dr. Reddy's Laboratory, Hyderabad, India

8.27 L

2017-2019

15

Development of epigenomes-targeted liposomes for the cancer-specific delivery of chemotherapeutic drug

Sun Pharmaceutical Advanced Research Company, Vadodara, India

29 L

2016-2019

16

Sustained release injectable depot formulation

Daewoong Pharmaceuticals, Hyderabad, India

22 L

2015-2017

17

Tumor-targeted nanomedicines for photodynamic therapy

DST (Indo-Belarus)

9.58 L

2015-2017

18

D-α tocopherol conjugated copolymer-based micelles for improved delivery of chemotherapeutics with reversal of multiple drug resistance

DST-Fast Track

22.4 L

2014-2017

19

Cell-penetrating peptide octa-arginine anchored, multifunctional poly(amidoamine) dendrimer to promote the delivery of chemotherapeutics in cancer

DBT-BIO-CARe

37.04 L

2014-2017

 

Extra-mural finding as Co-PI

Sr. No

Title of the projects

Funding agency

Fund

Duration

1

Bifunctional gene-expression modulating chemotherapeutic agents as an improved treatment strategy for cancer

CSIR

19.14 L

2018-2021

2

Design, Synthesis and Biological Evaluation of HDAC Selective Inhibitors as Long-term Memory Enhancers

DST-SERB-CRG

21.6 L

2016-2019